Perceiv AI

Perceiv.ai is a cutting-edge healthcare technology company specializing in the development of prognostic and predictive biomarkers for Alzheimer's disease and cardiovascular conditions. The company leverages advanced machine learning algorithms and clinical data to provide pre-screening strategies for identifying amyloid beta-positive subjects before an amyloid PET scan. This innovative approach aims to improve treatment outcomes by targeting responders and reprioritizing low-efficacy drugs using companion diagnostics (CDx). Perceiv.ai serves healthcare providers, researchers, and pharmaceutical companies, operating primarily in the medical diagnostics and biotechnology markets. The business model is centered around offering proprietary diagnostic tools and data analytics services, generating revenue through partnerships, licensing agreements, and direct sales of their diagnostic solutions.

Keywords: biomarkers, Alzheimer's, cardiovascular, machine learning, clinical data, diagnostics, healthcare, biotechnology, amyloid beta, CDx.